Cardiopulmonary Disorders
The term "Cardiopulmonary Disease" describes a range of conditions affecting the heart and lungs. These organs are closely related, and the problem in one can spill over to another. Exposure to tobacco smoke has long been recognized as an important component of cardiovascular risk. Likewise, minimizing your exposure to tobacco smoke is the most effective way to save you from COPD.
Common types of this condition include:
Chronical bronchitis.
Chronic obstructive pulmonary disease (COPD)
Chronic heart failure.
Emphysema.
Cardiopulmonary disease is the medical term used to describe quite number critical problems that affect the heart and lungs. The two-primary tobacco-associated cardiopulmonary illnesses are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Exposure to tobacco smoke has long been diagnosed as a prominent chance component for Cardiovascular Disease. Similarly minimizing exposure to tobacco smoke is the most effective manner to save you COPD. However, the mechanisms by way of which tobacco toxicants increase the danger of Cardiovascular Disease and result in the onset of COPD are nonetheless unclear. Despite discounts in smoking during the last decade, Cardiovascular Disease and COPD stay the first and second main causes of death among smokers. It is important to keep in mind also that for all of us who dies because of smoking as a minimum 30 people live with a critical smoking-associated illness.
The advent of e-cigarettes and other new tobacco products that deliver nicotine as an aerosol in a variety of solvents raises important new questions regarding the potential risk of cardiopulmonary disease among consumers. The use of this new tobacco product has skyrocketed over the past few years, especially among adolescents, and is expected to completely change the traditional cigarette market in the next decade. These new products deliver nicotine and chemical flavoring aerosols based on propylene glycol and / or glycerin by inhalation.
Related Conference of Cardiopulmonary Disorders
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
Cardiopulmonary Disorders Conference Speakers
Recommended Sessions
- Airway and Therapeutic Devices
- Asthma and Allergy
- Cardiopulmonary Disorders
- Case Reports in Pulmonology
- Chronic Bronchitis and Respiratory Diseases
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Diseases
- Obstructive sleep apnea
- Pediatric Pulmonology and Critical care
- Pulmonary Diseases and therapeutics
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Respiratory tract Infections
- Sarcoidosis
- Thoracic
- Tuberculosis
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- AI in Respiratory Care - COPD SUMMIT 2026 (Italy)
- Air Pollution & Tobacco Control - COPD SUMMIT 2026 (Italy)
- Asthma COPD Overlap (ACO) - COPD SUMMIT 2026 (Italy)
- Asthma: New Insights & Therapies - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Airway Techniques - COPD SUMMIT 2026 (Italy)
- COPD & Cardiovascular Diseases - COPD SUMMIT 2026 (Italy)
- COPD Diagnosis & Guidelines - COPD SUMMIT 2026 (Italy)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis - COPD SUMMIT 2026 (Italy)
- COPD Pharmacotherapy - COPD SUMMIT 2026 (Italy)
- COPD Prevention & Self-Management - COPD SUMMIT 2026 (Italy)
- COPD: Advances & Management - COPD SUMMIT 2026 (Italy)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - COPD SUMMIT 2026 (Italy)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Cancer: Diagnosis & Treatment - COPD SUMMIT 2026 (Italy)
- Lung Fibrosis - COPD SUMMIT 2026 (Italy)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Next-Gen COPD Treatments - COPD SUMMIT 2026 (Italy)
- Non-Invasive Ventilation (NIV) - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Respiratory Care - COPD SUMMIT 2026 (Italy)
- Personalized Pulmonary Medicine - COPD SUMMIT 2026 (Italy)
- Pneumonia & Tuberculosis - COPD SUMMIT 2026 (Italy)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Apnea - COPD SUMMIT 2026 (Italy)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
